Mediar Therapeutics
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease (NCT07473323) | Mediar Therapeutics | 2026-05-19 |
| EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc) (NCT07287670) | Mediar Therapeutics | 2026-04-16 |
| Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males (NCT07450521) | Mediar Therapeutics | 2026-02-18 |
| WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT06967805) | Mediar Therapeutics | 2025-05-05 |
| A First-in-Human Safety Trial of MTX-474 (NCT06535841) | Mediar Therapeutics | 2024-07-10 |
| A First-in-Human Safety Trial of MTX-463 (NCT06401213) | Mediar Therapeutics | 2024-04-15 |
Track Mediar Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.